ELAN Common Stock · Transaction Nov 4, 2025 · Filed Dec 8, 2025 · Amount pending receipt enrichment
Elanco Animal Health Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ELAN moving today?
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ELAN overview
Related filings and maps
Congress activity in ELAN
ELAN Common Stock · Transaction Nov 3, 2025 · Filed Dec 8, 2025 · Amount pending receipt enrichment
ELAN Common Stock · Transaction Oct 29, 2025 · Filed Nov 6, 2025 · Amount pending receipt enrichment
ELAN Common Stock · Transaction Oct 27, 2025 · Filed Nov 6, 2025 · Amount pending receipt enrichment
Elanco Animal Health Incorporated Common Stock · Transaction Sep 23, 2025 · Filed Oct 10, 2025 · $1,001 to $15,000
ELAN contract awards, year to date.
Public federal awards linked to this ticker.
ELAN lobbying filings, year to date.
Registered lobbying filings matched to Elanco Animal Health Inc.